Nancy Cox (virologist)

Last updated
Chief of the Influenza Branch for the National Center for Infectious Diseases, Nancy Cox, Ph.D., at the podium during a Centers for Disease Control (CDC) press briefing. Nancy Cox.jpg
Chief of the Influenza Branch for the National Center for Infectious Diseases, Nancy Cox, Ph.D., at the podium during a Centers for Disease Control (CDC) press briefing.

Nancy J. Cox [1] (born 1949) is an American virologist who has served as the director of the Influenza Division at the Centers for Disease Control and Prevention (CDC) from 2006 to 2014 and as director of the CDC's World Health Organization (WHO) Collaborating Center for Surveillance, Epidemiology and Control of Influenza from 1992 to 2014. Cox served as the Chair and Co-Chair of the Scientific Advisory Council of the GISAID Initiative, between the years 2008 and 2017 and is frequently recognized for having played an instrumental role in the success of GISAID. [2] [3]

Biography

Nancy J. Cox was born in 1949 and is a native of Curlew, Iowa. [4] She was educated at Iowa State University, graduating in 1970 with a degree in Bacteriology. [5] [4] Dr. Cox was awarded a Marshall Scholarship to study in England at the University of Cambridge at Darwin College, Cambridge, where in 1975 she earned a doctoral degree in virology. [6]

Dr. Cox started working on influenza at the CDC in 1976. [4] She retired in December 2014, after 37 years and 278 publications. Over the course of her career, Cox helped transform the surveillance and science of influenza viruses and vaccines worldwide. At the CDC, she set the standards for measuring immune response in infected and vaccinated people, and also led the agency to be the global reference center for antiviral resistance and for measuring transmission of influenza viruses in animal models. As director of the World Health Organization (WHO) Collaborating Center for the Surveillance, Epidemiology and Control of Influenza at the CDC, Cox worked closely with public health officials from Russia, Vietnam and China, helping to transform their capabilities in influenza virology and surveillance. Her work with WHO also led to significant changes in the methods, reporting, interpretation, and policy development for selecting vaccine viruses for use in annual influenza vaccine production.

Cox has been the recipient of ten CDC recognition awards, seven Nakano Awards, four Shepard Awards, The Lancet ’s “Paper of the Year,” Time Magazine ’s “The Time 100: People Who Shape Our World,” the Service to America Award, CDC's Lifetime Achievement Award and the US Government Federal Employee of the Year award.

Related Research Articles

<span class="mw-page-title-main">Centers for Disease Control and Prevention</span> United States government public health agency

The Centers for Disease Control and Prevention (CDC) is the national public health agency of the United States. It is a United States federal agency, under the Department of Health and Human Services, and is headquartered in Atlanta, Georgia.

<span class="mw-page-title-main">Influenza vaccine</span> Vaccine against influenza

Influenza vaccines, also known as flu shots, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed twice a year, as the influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza. The United States Centers for Disease Control and Prevention (CDC) estimates that vaccination against influenza reduces sickness, medical visits, hospitalizations, and deaths. Immunized workers who do catch the flu return to work half a day sooner on average. Vaccine effectiveness in those over 65 years old remains uncertain due to a lack of high-quality research. Vaccinating children may protect those around them.

<span class="mw-page-title-main">Swine influenza</span> Infection caused by influenza viruses endemic to pigs

Swine influenza is an infection caused by any of several types of swine influenza viruses. Swine influenza virus (SIV) or swine-origin influenza virus (S-OIV) refers to any strain of the influenza family of viruses that is endemic in pigs. As of 2009, identified SIV strains include influenza C and the subtypes of influenza A known as H1N1, H1N2, H2N1, H3N1, H3N2, and H2N3.

<span class="mw-page-title-main">Flu season</span> Recurring periods of influenza

Flu season is an annually recurring time period characterized by the prevalence of an outbreak of influenza (flu). The season occurs during the cold half of the year in each hemisphere. It takes approximately two days to show symptoms. Influenza activity can sometimes be predicted and even tracked geographically. While the beginning of major flu activity in each season varies by location, in any specific location these minor epidemics usually take about three weeks to reach its pinnacle, and another three weeks to significantly diminish.

<span class="mw-page-title-main">Influenza A virus subtype H1N1</span> Subtype of Influenza A virus

In virology, influenza A virus subtype H1N1 (A/H1N1) is a subtype of influenza A virus. Major outbreaks of H1N1 strains in humans include the Spanish flu, the 1977 Russian flu pandemic and the 2009 swine flu pandemic. It is an orthomyxovirus that contains the glycoproteins hemagglutinin and neuraminidase. For this reason, they are described as H1N1, H1N2 etc., depending on the type of H or N antigens they express with metabolic synergy. Hemagglutinin causes red blood cells to clump together and binds the virus to the infected cell. Neuraminidase is a type of glycoside hydrolase enzyme which helps to move the virus particles through the infected cell and assist in budding from the host cells.

<i>Influenza B virus</i> Species of virus

Influenza B virus is the only species in the genus Betainfluenzavirus in the virus family Orthomyxoviridae.

OFFLU is the joint OIE-FAO global network of expertise on animal influenzas. OFFLU aims to reduce the negative impacts of animal influenza viruses by promoting effective collaboration between animal health experts and with the human health sector. OFFLU analyses and shares information and biological material to identify and reduce health threats early, and shares information about animal influenza viruses with the World Health Organization (WHO) to assist with the early preparation of human vaccines. It was established in 2005, initially to support the global effort to control H5N1 highly pathogenic avian influenza.

<span class="mw-page-title-main">Pandemic severity index</span> Proposed measure of the severity of influenza

The pandemic severity index (PSI) was a proposed classification scale for reporting the severity of influenza pandemics in the United States. The PSI was accompanied by a set of guidelines intended to help communicate appropriate actions for communities to follow in potential pandemic situations. Released by the United States Department of Health and Human Services (HHS) on February 1, 2007, the PSI was designed to resemble the Saffir-Simpson Hurricane Scale classification scheme. The index was replaced by the Pandemic Severity Assessment Framework in 2014, which uses quadrants based on transmissibility and clinical severity rather than a linear scale.

<span class="mw-page-title-main">GISAID</span> Global initiative for sharing virus data

GISAID is a global science initiative and primary source established in 2008 that provides open access to genomic data of influenza viruses and the coronavirus responsible for the COVID-19 pandemic. On January 10, 2020, the first whole-genome sequences of SARS-CoV-2 were made available on GISAID, which enabled global responses to the pandemic, including the development of the first vaccines and diagnostic tests to detect SARS-CoV-2. The database has become the world's largest repository for SARS-CoV-2 sequences. GISAID facilitates genomic epidemiology and real-time surveillance to monitor the emergence of new COVID-19 viral strains across the planet.

The National Institute of Virology in Pune, India is an Indian virology research institute and part of the Indian Council of Medical Research (ICMR). It was previously known as 'Virus Research Centre' and was founded in collaboration with the Rockefeller Foundation. It has been designated as a WHO H5 reference laboratory for SE Asia region.

<span class="mw-page-title-main">Siti Fadilah Supari</span>

Siti Fadilah Supari, is a cardiology research specialist, a former health minister of Indonesia. She gained global notoriety in 2007 when she took on the World Health Organization's practice of sharing avian influenza virus samples.

<span class="mw-page-title-main">Influenza-like illness</span> Medical diagnosis

Influenza-like illness (ILI), also known as flu-like syndrome or flu-like symptoms, is a medical diagnosis of possible influenza or other illness causing a set of common symptoms. These include fever, shivering, chills, malaise, dry cough, loss of appetite, body aches, and nausea, sneezing typically in connection with a sudden onset of illness. In most cases, the symptoms are caused by cytokines released by immune system activation, and are thus relatively non-specific.

<span class="mw-page-title-main">Katherine O'Brien</span> Canadian-born pediatric physician (born 1963)

Katherine "Kate" L. O'Brien is a Canadian American pediatric infectious disease physician, epidemiologist, and vaccinologist who specializes in the areas of pneumococcal epidemiology, pneumococcal vaccine trials and impact studies, and surveillance for pneumococcal disease. She is also known as an expert in infectious diseases in American Indian populations. O’Brien is currently the Director of the World Health Organization's Department of Immunization, Vaccines and Biologicals.

<span class="mw-page-title-main">2009 swine flu pandemic</span> 2009–2010 pandemic of swine influenza caused by H1N1 influenza virus

The 2009 swine flu pandemic, caused by the H1N1 influenza virus and declared by the World Health Organization (WHO) from June 2009 to August 2010, is the third recent flu pandemic involving the H1N1 virus. The first two cases were discovered independently in the United States in April 2009. The virus appeared to be a new strain of H1N1 that resulted from a previous triple reassortment of bird, swine, and human flu viruses which further combined with a Eurasian pig flu virus, leading to the term "swine flu".

The 2009 flu pandemic in the United States was caused by a novel strain of the Influenza A/H1N1 virus, commonly referred to as "swine flu", that was first detected on 15 April 2009. While the 2009 H1N1 virus strain was commonly referred to as "swine flu", there is no evidence that it is endemic to pigs or of transmission from pigs to people; instead, the virus spreads from person to person. On April 25, the World Health Organization declared a public health emergency, followed concurringly by the Obama administration on April 26.

<span class="mw-page-title-main">Chinese Center for Disease Control and Prevention</span> Chinese public health agency

The Chinese Center for Disease Control and Prevention is an institution directly under the National Health Commission, based in Changping District, Beijing, China.

<span class="mw-page-title-main">Pandemic H1N1/09 virus</span> Virus responsible for the 2009 swine flu pandemic

The pandemic H1N1/09 virus is a swine origin influenza A virus subtype H1N1 strain that was responsible for the 2009 swine flu pandemic. This strain is often called swine flu by the public media. For other names, see the Nomenclature section below.

<span class="mw-page-title-main">Viktor Zhdanov</span>

Viktor Mikhailovich Zhdanov was a Soviet and Ukrainian scientist, virologist and epidemiologist. He was instrumental in the effort to eradicate smallpox globally.

<span class="mw-page-title-main">1957–1958 influenza pandemic</span> Pandemic of influenza virus (H2N2)

The 1957–1958 Asian flu pandemic was a global pandemic of influenza A virus subtype H2N2 that originated in Guizhou in Southern China. The number of excess deaths caused by the pandemic is estimated to be 1–4 million around the world, making it one of the deadliest pandemics in history. A decade later, a reassorted viral strain H3N2 further caused the Hong Kong flu pandemic (1968–1969).

<span class="mw-page-title-main">Jacqueline Katz</span> Australian-American microbiologist

Jacqueline Marion Katz is an Australian-American microbiologist serving as the deputy director of the influenza division at the National Center for Immunization and Respiratory Diseases.

References

  1. "PIP Framework, Biography of Nancy J. Cox", World Health Organization, Geneva. Retrieved on 2016-11-16.
  2. Elbe, Stefan; Buckland-Merrett, Gemma (2017-01-01). "Data, disease and diplomacy: GISAID's innovative contribution to global health". Global Challenges. 1 (1): 33–46. doi:10.1002/gch2.1018. ISSN   2056-6646. PMC   6607375 . PMID   31565258.
  3. "GISAID - Governance". www.gisaid.org. Retrieved 2017-09-07.
  4. 1 2 3 Squires, Heather (2015-01-02). "Former Resident Retires From Career With CDC". Emmetsburg News. Retrieved 2018-11-19.
  5. "Distinguished Alumni". Iowa State University, Office of Admissions. Retrieved 2018-11-19.
  6. "Influenza: Tracking a Moving Target in a Rapidly Changing World". Iowa State University of Science and Technology, Nanovaccine Institute. 2014. Retrieved 2018-11-19.
Government offices
Preceded by
Director of the Influenza Division at the Centers for Disease Control and Prevention
2006-2014
Succeeded by
Daniel B. Jernigan [1]
Non-profit organization positions
Preceded by
Director of the WHO Collaborating Center for Surveillance, Epidemiology and Control of Influenza, Atlanta
1992-2014
Succeeded by
Jacqueline M. Katz [2]
Educational offices
New title Co-Chair of GISAID Scientific Advisory Council
2008–2017
Succeeded by
Jacqueline M. Katz
  1. "CDCNCIRS - Influenza Division". www.cdc.gov. Retrieved 2017-09-07.
  2. "CDCNCIRS - Influenza Division". www.cdc.gov. Retrieved 2017-09-07.